- Home
- XGN vs ARQQ Comparison
XGN vs ARQQ Comparison
Compare XGN & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- ARQQ
- Stock Information
- Founded
- XGN 2002
- ARQQ 2017
- Country
- XGN United States
- ARQQ United Kingdom
- Employees
- XGN N/A
- ARQQ N/A
- Industry
- XGN Medical Specialities
- ARQQ Computer Software: Prepackaged Software
- Sector
- XGN Health Care
- ARQQ Technology
- Exchange
- XGN Nasdaq
- ARQQ Nasdaq
- Market Cap
- XGN 72.3M
- ARQQ 282.1M
- IPO Year
- XGN 2019
- ARQQ N/A
- Fundamental
- Price
- XGN $5.15
- ARQQ $29.29
- Analyst Decision
- XGN Buy
- ARQQ Strong Buy
- Analyst Count
- XGN 1
- ARQQ 1
- Target Price
- XGN $7.00
- ARQQ $27.00
- AVG Volume (30 Days)
- XGN 163.8K
- ARQQ 1.4M
- Earning Date
- XGN 11-12-2024
- ARQQ 12-31-2024
- Dividend Yield
- XGN N/A
- ARQQ N/A
- EPS Growth
- XGN N/A
- ARQQ N/A
- EPS
- XGN N/A
- ARQQ N/A
- Revenue
- XGN $55,751,000.00
- ARQQ $293,000.00
- Revenue This Year
- XGN $6.74
- ARQQ $3,516.04
- Revenue Next Year
- XGN $17.32
- ARQQ N/A
- P/E Ratio
- XGN N/A
- ARQQ N/A
- Revenue Growth
- XGN 8.00
- ARQQ N/A
- 52 Week Low
- XGN $1.30
- ARQQ $3.72
- 52 Week High
- XGN $6.22
- ARQQ $42.90
- Technical
- Relative Strength Index (RSI)
- XGN 58.53
- ARQQ 56.31
- Support Level
- XGN $4.71
- ARQQ $22.30
- Resistance Level
- XGN $6.22
- ARQQ $42.90
- Average True Range (ATR)
- XGN 0.55
- ARQQ 6.82
- MACD
- XGN -0.02
- ARQQ 0.02
- Stochastic Oscillator
- XGN 46.23
- ARQQ 31.69
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.